Orphan designation: Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4 Treatment of ovarian cancer, 19/03/2015 Positive

Submitted by Anonymous (not verified) on 28 October 2024 - 8:00

Orphan designation: Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4 Treatment of ovarian cancer, 19/03/2015 Positive

Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of ornithine-translocase deficiency, 17/07/2013 Positive

Submitted by Anonymous (not verified) on 28 October 2024 - 7:30

Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of ornithine-translocase deficiency, 17/07/2013 Positive

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 25 October 2024 - 14:15

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 19, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More